Results 61 to 70 of about 19,188,680 (306)

Update on the second-line treatment of infection: a narrative review

Therapeutic Advances in Gastroenterology, 2023
A standard bismuth quadruple therapy, a fluoroquinolone-containing triple (or quadruple) therapy or a proton pump inhibitor (PPI)-amoxicillin high-dose dual therapy has been recommended as a second-line treatment for Helicobacter pylori infection by the ...
Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai, Seng-Kee Chuah, Hsi-Chang Lee, Ping-I Hsu   +5 more
doaj   +1 more source

Type of chemotherapy in second-line treatment.

, 2019
Type of chemotherapy in second-line treatment.
Magdalena Piróg (6281519), Lubomir Bodnar (6281510), Dorota Babczyk (6281516), Tomasz Basta (6281501), Robert Jach (6281531), Anna Horbaczewska (6281528), Paweł Knapp (6281504), Iwona Gawron (6281513), Paweł Blecharz (6281507), Anna Markowska (6281525), Tomasz Kluz (6281522)   +10 more
core   +1 more source

Feeding, Fear, and Acceptance: Caregivers’ Experiences of Nutritional Support During Childhood Cancer Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose To explore caregivers' experiences and perceptions of the nutritional challenges faced by children and adolescents undergoing cancer treatment, including oral intake and the use of nutritional support. Methods This was a qualitative study based on focus groups with parents and caregivers at a Brazilian pediatric oncology hospital ...
Danyelle Apparecida Balsamão Marques, Mariana dos Santos Murra, Welinton Hirai, Ana Laura Balduino do Nascimento, Karla Emilia de Sá Rodrigues, Wilson Elias de Oliveira Junior   +5 more
wiley   +1 more source

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Drug Design, Development and Therapy, 2011
Channing J Paller, Emmanuel S AntonarakisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USAAbstract: Until recently, patients with castration-resistant prostate cancer (CRPC) had limited therapeutic options once they became ...
Channing J Paller, Emmanuel S Antonarakis   +1 more
doaj  

Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes. [PDF]

, 2018
BACKGROUND After first-line antiretroviral therapy (ART) failure, the importance of change in nucleoside reverse transcriptase inhibitor (NRTI) in second-line is uncertain due to the high potency of protease inhibitors used in second-line. SETTING
Horsburgh, C Robert, Giddy, Janet, Hans Prozesky, Janet Giddy, Mwanza wa Mwanza, Ive, Prudence, Wandeler, Gilles, Berhanu, Rebecca, Charles Robert Horsburgh, Christopher J. Hoffmann, Robin Wood, Vinikoor, Michael, Gilles Wandeler, Fox, Matthew P, Rebecca Berhanu, Hoffmann, Christopher J, Julia K. Rohr, Prudence Ive, Mwanza, Mwanza Wa, Rohr, Julia K, Boulle, Andrew, Prozesky, Hans, Mary-Ann Davies, Matthew P. Fox, Davies, Mary-Ann, Andrew Boulle, Michael Vinikoor, Wood, Robin, Rohr JK, Vinikoor M, Ive P, Wandeler G, Giddy J, Hoffmann CJ, Berhanu R, Boulle A, Fox MP, Horsburgh CR, Prozesky H, Davies MA, Wood R, Mwanza MW   +41 more
core   +2 more sources

Uncovering Inequities: The Role of Social Determinants of Health in Hospitalized Adolescents and Young Adults With Heavy Menstrual Bleeding

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Heavy menstrual bleeding (HMB) is a common condition among adolescents and young adults (AYAs) and is the leading cause of iron deficiency anemia (IDA) in this population. Growing evidence suggests that social determinants of health (SDOH) influence menstrual bleeding patterns, access to care, and treatment. However, no studies have
Maria Carter‐Febres, Cristina Tarango, Ashley Childress, Chunyan Liu, Evan Thomas, Jennifer Pomales, Eric S. Mullins   +6 more
wiley   +1 more source

Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers

Biologics: Targets & Therapy, 2021
Mimma Rizzo,1 Patrizia Giannatempo,2 Camillo Porta1,3 1Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy; 2Department of Medical Oncology, Fondazione I.R.C.C.S.
Rizzo M, Giannatempo P, Porta C
doaj  

Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms. [PDF]

, 2017
BACKGROUND Second-line systemic treatment options for metastatic clear cell renal cell cancer (mccRCC) are diverse and treatment strategies are variable among experts.
Porta C., Grunwald V., Putora, PM, Larkin J., Schmidinger M., Rothermundt, C, Rini B., Putora, Paul Martin, Eisen, T, Rini, B, Sternberg, C N, Oldenburg, J, McDermott, D, Putora P. M., Porta, C, von Rappard J., Rothermundt C., Grünwald, V, Oldenburg J., Schmidinger, M, Sternberg, CN, Sternberg C. N., Escudier B., Larkin, J, Eisen T., McDermott D., Escudier, B, von Rappard, J, von Rappard J, McDermott D, Sternberg CN, Oldenburg J, Schmidinger M, Putora PM, Porta C, Rothermundt C, Rini B, Escudier B, Larkin J, Eisen T, Grünwald V   +40 more
core   +2 more sources

Organoids in pediatric cancer research

FEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. [PDF]

, 2010
To view this article, click on "Additional Links".CONTEXT: Long-term antiretroviral therapy (ART) use in resource-limited countries leads to increasing numbers of patients with HIV taking second-line therapy. Limited access to further therapeutic options
Mar Pujades-Rodríguez, Pujades-Rodríguez, Mar, Calmy, Alexandra, Brinkhof, Martin A W, Balkan, Suna, Arnould, Line, Brinkhof, Martin A. W.   +6 more
core   +1 more source